Literature DB >> 15546958

A rich chemokine environment strongly enhances leukocyte migration and activities.

Samantha Paoletti1, Vibor Petkovic, Silvia Sebastiani, M Gabriela Danelon, Mariagrazia Uguccioni, Basil O Gerber.   

Abstract

The migration of leukocytes in immune surveillance and inflammation is largely determined by their response to chemokines. While the chemokine specificities and expression patterns of chemokine receptors are well defined, it is still a matter of debate how leukocytes integrate the messages provided by different chemokines that are concomitantly produced in physiologic or pathologic situations in vivo. We present evidence for a novel regulatory mechanism of leukocyte trafficking. Our data are consistent with a mode of action where CC-chemokine receptor 7 (CCR7) agonists and unrelated, nonagonist chemokines first form a heteromeric complex, in the presence of which the triggering of CCR7 can occur at a much lower agonist concentration. The increase is synergistic and can be evoked by many but not all chemokines. Chemokine-induced synergism might provide an amplification system in "chemokine-rich" tissues, rendering leukocytes more competent to respond to migratory cues.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15546958     DOI: 10.1182/blood-2004-04-1648

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  28 in total

Review 1.  Chemokines and chemokine receptors: update on utility and challenges for the clinician.

Authors:  Ishan Roy; Douglas B Evans; Michael B Dwinell
Journal:  Surgery       Date:  2014-02-08       Impact factor: 3.982

2.  Diflunisal targets the HMGB1/CXCL12 heterocomplex and blocks immune cell recruitment.

Authors:  Federica De Leo; Giacomo Quilici; Mario Tirone; Francesco De Marchis; Valeria Mannella; Chiara Zucchelli; Alessandro Preti; Alessandro Gori; Maura Casalgrandi; Rosanna Mezzapelle; Marco E Bianchi; Giovanna Musco
Journal:  EMBO Rep       Date:  2019-08-14       Impact factor: 8.807

3.  Chemokine cooperativity is caused by competitive glycosaminoglycan binding.

Authors:  Guido J R Zaman; Martine J Smit; Folkert Verkaar; Jody van Offenbeek; Miranda M C van der Lee; Lambertus H C J van Lith; Anne O Watts; Angelique L W M M Rops; David C Aguilar; Joshua J Ziarek; Johan van der Vlag; Tracy M Handel; Brian F Volkman; Amanda E I Proudfoot; Henry F Vischer
Journal:  J Immunol       Date:  2014-03-17       Impact factor: 5.422

4.  Immune-related chemotactic factors were found in acute coronary syndromes by bioinformatics.

Authors:  Lei Zhang; Jian Li; Aibin Liang; Yang Liu; Bing Deng; Hao Wang
Journal:  Mol Biol Rep       Date:  2014-03-06       Impact factor: 2.316

5.  Role of the C-C chemokine receptor-2 in a murine model of injury-induced osteoarthritis.

Authors:  L Longobardi; J D Temple; L Tagliafierro; H Willcockson; A Esposito; N D'Onofrio; E Stein; T Li; T J Myers; H Ozkan; M L Balestrieri; V Ulici; R F Loeser; A Spagnoli
Journal:  Osteoarthritis Cartilage       Date:  2016-11-14       Impact factor: 6.576

Review 6.  Chemokines in homeostasis and diseases.

Authors:  Keqiang Chen; Zhiyao Bao; Peng Tang; Wanghua Gong; Teizo Yoshimura; Ji Ming Wang
Journal:  Cell Mol Immunol       Date:  2018-01-29       Impact factor: 11.530

Review 7.  Therapeutic targeting of chemokine interactions in atherosclerosis.

Authors:  Rory R Koenen; Christian Weber
Journal:  Nat Rev Drug Discov       Date:  2010-02       Impact factor: 84.694

8.  The Chemokine Receptor CCR8 Promotes the Migration of Dendritic Cells into the Lymph Node Parenchyma to Initiate the Allergic Immune Response.

Authors:  Caroline L Sokol; Ryan B Camire; Michael C Jones; Andrew D Luster
Journal:  Immunity       Date:  2018-08-28       Impact factor: 31.745

9.  Endometrial CXCL13 expression is cycle regulated in humans and aberrantly expressed in humans and Rhesus macaques with endometriosis.

Authors:  Jason M Franasiak; Katherine A Burns; Ov Slayden; Lingwen Yuan; Marc A Fritz; Kenneth S Korach; Bruce A Lessey; Steven L Young
Journal:  Reprod Sci       Date:  2014-07-16       Impact factor: 3.060

10.  Disrupting functional interactions between platelet chemokines inhibits atherosclerosis in hyperlipidemic mice.

Authors:  Rory R Koenen; Philipp von Hundelshausen; Irina V Nesmelova; Alma Zernecke; Elisa A Liehn; Alisina Sarabi; Birgit K Kramp; Anna M Piccinini; Søren R Paludan; M Anna Kowalska; Andreas J Kungl; Tilman M Hackeng; Kevin H Mayo; Christian Weber
Journal:  Nat Med       Date:  2009-01-04       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.